Incyte (INCY) Times Interest Earned (2010 - 2026)
Incyte's (INCY) quarterly Times Interest Earned came in at $110.78 in Q2 2026, up 19.07% YoY from $93.04 in Q2 2025, and up 135.45% on a QoQ basis from $47.05 in Q1 2026.
Analysis
Incyte (INCY) Times Interest Earned (2010 - 2026) Analysis & Trends
Incyte (INCY) has 17 years of Times Interest Earned data on file, last reported at $110.78 in Q2 2026.
- Quarterly Times Interest Earned rose 19.07% year-over-year to $110.78 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1125.6 (down 2145.48% YoY) and the FY2025 annual result came in at $67.63, up 235699.99% from the prior year.
- Times Interest Earned rose to $110.78 in Q2 2026, from $47.05 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $749.19 in Q3 2025 to a low of -$91.95 in Q2 2024.
- A 5-year average of $73.29 and a median of $39.16 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned slumped 289.8% — and 2025, when it surged 2566.78%.
- Tracing INCY's Times Interest Earned over 5 years: stood at $105.09 in 2022, then slumped by 114.79% to -$15.54 in 2023, then surged by 504.15% to $62.82 in 2024, then sank by 135.95% to -$22.58 in 2025, then jumped by 590.53% to $110.78 in 2026.
- The last three Times Interest Earned figures came in at $110.78 (Q2 2026), $47.05 (Q1 2026), and -$22.58 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 1,199.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,199.14 |
| Mar 31, 2026 | 529.20 |
| Dec 31, 2025 | 577.08 |
| Sep 30, 2025 | 749.19 |
| Jun 30, 2025 | 892.78 |
| Mar 31, 2025 | 310.86 |
| Dec 31, 2024 | 719.60 |
| Sep 30, 2024 | 188.74 |
| Jun 30, 2024 | -727.75 |
| Mar 31, 2024 | 213.72 |
| Dec 31, 2023 | 232.92 |
| Sep 30, 2023 | 344.63 |
| Jun 30, 2023 | 295.85 |
| Mar 31, 2023 | 52.81 |
| Dec 31, 2022 | 105.09 |
| Sep 30, 2022 | 215.88 |
| Jun 30, 2022 | 375.27 |
| Mar 31, 2022 | 171.38 |
| Dec 31, 2021 | 147.25 |
| Sep 30, 2021 | 536.24 |